<DOC>
	<DOC>NCT00410592</DOC>
	<brief_summary>This study will be conducted in order to determine safety and efficacy esomeprazole, lansoprazole and pantoprazole control stomach acid by measuring the stomach acid in men and women of Hispanic origin who have GERD.</brief_summary>
	<brief_title>Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Signed informed consent Males and females ages 1869 who are of Hispanic origin Symptoms of GERD, defined as heartburn at least 2 times a week on average over the last 3 months Female patients who are pregnant or breastfeeding Known intolerance or lack of response to Proton Pump Inhibitors (PPIs) such as Nexium, Prevacid, or Protonix Current or relevant history of nonhealed ulcers, stomach surgery, or esophageal surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>GERD</keyword>
	<keyword>acid reflux</keyword>
	<keyword>heartburn</keyword>
	<keyword>PPI</keyword>
	<keyword>Hispanic</keyword>
</DOC>